Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

von Willebrand Factor fibers formed at pathological high shear provide a scaffold for α-synuclein binding and aggregation.

Scientific reports·2026

Same author

Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk.

Blood·2026

Same author

From imaging to computational domains for physics-driven molecular biology simulations: Hindered diffusion in platelet masses.

PLoS computational biology·2025

Same author

Multiscale simulations that incorporate patient-specific neural network models of platelet calcium signaling predict diverse thrombotic outcomes under flow.

PLoS computational biology·2025

Same author

Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under Flow.

TH open : companion journal to thrombosis and haemostasis·2025

Same author

From imaging to computational domains for physics-driven molecular biology simulations: Hindered diffusion in platelet masses.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: Mar 22, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Systems Analysis of Thrombus Formation.

Scott L Diamond¹

¹From the Department of Chemical Engineering, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia. sld@seas.upenn.edu.

Circulation Research

|April 30, 2016

Summary

Systems biology quantitatively predicts blood clot formation in arteries and veins. This approach offers metrics for clot growth, thrombotic risk, and therapeutic targets, aiding in predicting heart attacks and strokes.

Keywords:

blood platelets fibrin hemodynamics thrombin von Willebrand factor

More Related Videos

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Related Experiment Videos

Last Updated: Mar 22, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Area of Science:

Biomedical Engineering
Computational Biology
Hematology

Background:

Thrombosis involves complex interactions of blood components, vessel walls, and hemodynamics.
Arterial and venous thrombosis differ in their underlying mechanisms, including flow conditions and cellular contributors.
Understanding these differences is crucial for developing targeted therapies.

Purpose of the Study:

To establish a quantitative systems biology framework for predicting thrombosis.
To develop metrics for clot growth rate, thrombotic risk, and drug response.
To evaluate the efficacy of novel therapeutic strategies.

Main Methods:

Utilizing computational fluid dynamics (CFD) for patient-specific hemodynamic analysis.
Employing high-dimensional ex vivo phenotyping of platelets and coagulation factors.
Developing multiscale computer simulations from subcellular to whole vessel levels.

Main Results:

Distinguishing key differences in thrombosis drivers between arterial (atherosclerosis, high shear stress) and venous (stasis, inflammation) systems.
Enabling patient-specific assessment of hemodynamics and fractional flow reserve.
Providing a foundation for simulating thrombotic events like heart attacks and strokes.

Conclusions:

A systems biology approach offers a powerful tool for quantitative thrombosis prediction.
This framework can guide the development and evaluation of pharmacological interventions.
It facilitates the ranking of safety and efficacy metrics for clinical trial designs.